From FDA clearances to touting study data, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. XpandOrtho wins FDA 510(k) clearance XpandOrtho announced in a May 17 press release that it has received FDA 510(k) clearance for its electronic soft tissue balancing instrument for total knee replacement surgery. […]
Exactech Inc.
Exactech deals spine biz to ChoiceSpine
Exactech (NSDQ:EXAC) said it sold off its spine business yesterday to ChoiceSpine for an undisclosed amount and plans to restructure its biologics business. “For nearly a decade, Exactech has driven innovations in spinal surgery and we are pleased to have made meaningful contributions to patient care. We are confident the transfer of these products to ChoiceSpine will […]
Exactech wins FDA 510(k) for Vantage total ankle.
Exactech (NSDQ:EXAC) said today it won FDA 510(k) clearance for its Vantage total ankle designed to treat patients with arthritis in the ankle. The Vantage total ankle is designed for total ankle arthroplasty, with a curved surface talar component and curved talus and anatomic tibia designs, the Gainesville, Fla.-based company said. The device incorporates a press-fit […]
Exactech deals dental assets to Salvin Dental Specialties
Exactech (NSDQ:EXAC) said today it sold the entirety of its dental biologics business to Salvin Dental Specialties, through its Salvin Regenerative subsidiary. Financial terms and other details of the deal were not disclosed. Salvin Dental develops, manufactures and markets implant dentistry regenerative biomaterials and surgical instrumentation, Exactech said. “While it has been a pleasure to […]
NASS 2015 Roundup: Spine trends stabilizing, new fields taking center stage
The spinal med device market appears to be stabilizing with growth in 3 key areas, according to a letter to investors published this week from Leerink Partner’s Richard Newitter, who attended the North American Spine Society’s annual meeting in Chicago last week. Newitter said the meeting was “neutral-to-positive” for firms in the spinal market, and said […]
Exactech launches Opterak revision knee system
Exactech (NSDQ:EXAC) said yesterday it launched its Opterak revision knee system and that the system has been successfully implanted in its 1st set of patients. The revision knee system is composed of proprietary net compression molded polyethylene and is indicated for use in skeletally mature patients undergoing surgery for total knee replacements due to osteoarthritis, osteonecrosis, […]
Exactech wins FDA 510(k) for Optetrak knee prosthesis
Exactech (NSDQ:EXAC) said yesterday that it won FDA 510(k) clearance for its Optetrak Logic constrained condylar prosthesis for revision knee arthroplasty patients. The knee prosthesis is approved for indications in patients undergoing total knee replacement due to osteoarthritis, osteonecrosis, rheumatoid arthritis, post-traumatic degenerative problems and to replace failed knee devices, the Gainesville, Fla-based company said. […]
Baxter adds 30 jobs in Malta | Medtech personnel moves for the week of Apr. 7, 2014
Report: Baxter to add 30 jobs in Malta
April 2, 2014 by Arezu Sarvestani
Malta regulators announced this week that healthcare titan Baxter plans to add 30 additional jobs in the country.
Z-Medica taps ex-Solta Medical CEO Fanning | Personnel Moves
Z-Medica said it named Stephen Fanning, the former CEO of Solta Medical, to be its new chief executive.
Wallingford, Conn.-based Z-Medica is developing blood clotting technologies it calls QuikClot.
Exactech beats Wall Street, boosts earnings guidance after strong Q3
Insulet appoints 1st medical director | Personnel Moves
Insulet (NSDQ:PODD) said it named Dr. Howard Zisser, the former clinical director of the Sansum Diabetes Research Institute, as its 1st medical director.
Considered a leader in diabetes research, Zisser will be involved with a variety of clinical research projects and serve as a medical liaison between Insulet and government leaders, the FDA, and healthcare organizations, Bedford, Mass.-based Insulet said.
